O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/4/2020ACC: 0001209191-20-044662
Officer· Chief Medical Officer
Since Jun 2018
+60.00
Net shares
Net buyer
$927.30
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30.00
Price / share
$30.91
Trade value
$927.30
% of position
1.4%
7/31/2020
2.10K→2.13K
Total
Net shares
+30.00
Net value
$927.30
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2020 | A · Award | +30.00 | $30.91 | $927.30 | 1.4% | 2.10K | 2.13K |
| Total | +30.00 | $927.30 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30.00 shares
Shares
+30.00
Strike price
36.37
Held after
30.00
Exercisable
—
7/31/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock30.00 shares | 7/31/2020 | A · Award | +30.00 | 36.37 | — | 30.00 |